Papers - SATO Atsushi
-
[Skin toxicity].
Sato A, Hamada K, Imataka H
Gan to kagaku ryoho. Cancer & chemotherapy 38 ( 11 ) 1767 - 72 2011.11
-
[Phase I / II study of XELOX plus bevacizumab in Japanese patients with metastatic colorectal cancer(JO19380)].
Atsushi Sato, Toshihiko Doi, Narikazu Boku, Ken Kato, Yoshito Komatsu, Kensei Yamaguchi, Kei Muro, Yasuo Hamamoto, Wasaburo Koizumi, Nobuyuki Mizunuma, Hiroya Takiuchi
Gan to kagaku ryoho. Cancer & chemotherapy 38 ( 4 ) 561 - 569 2011.4
-
[Phase I / II study of XELOX plus bevacizumab in Japanese patients with metastatic colorectal cancer(JO19380)].
Sato A, Doi T, Boku N, Kato K, Komatsu Y, Yamaguchi K, Muro K, Hamamoto Y, Koizumi W, Mizunuma N, Takiuchi H
Gan to kagaku ryoho. Cancer & chemotherapy 38 ( 4 ) 561 - 9 2011.4
-
Phase I/II study of capecitabine plus oxaliplatin (XELOX) plus bevacizumab as first-line therapy in Japanese patients with metastatic colorectal cancer.
Toshihiko Doi, Narikazu Boku, Ken Kato, Yoshito Komatsu, Kensei Yamaguchi, Kei Muro, Yasuo Hamamoto, Atsushi Sato, Wasaburo Koizumi, Nobuyuki Mizunuma, Hiroya Takiuchi
Japanese journal of clinical oncology 40 ( 10 ) 913 - 920 2010.10
-
アミオダロン塩酸塩速崩錠「ＴＨ｝の健康成人における薬物動態
高野和彦，長井晶彦，佐藤隆，佐藤温
診療と新薬 47 ( 9 ) 898 - 903 2010.9
-
[The European Organisation for Research and Treatment of Cancer (EORTC) Quality of Life Questionnaire for Japanese patients with bone metastases--The Japanese version of the EORTC QLQ-BM22].
Takefumi Satoh, Kunihiko Kobayashi, Taisuke Hori, Shinsuke Iida, Atsushi Sato, Hiroshi Ishiguro, Edward Chow, Kojiro Shimozuma
Gan to kagaku ryoho. Cancer & chemotherapy 37 ( 8 ) 1507 - 1512 2010.8
-
[The European Organisation for Research and Treatment of Cancer (EORTC) Quality of Life Questionnaire for Japanese patients with bone metastases--The Japanese version of the EORTC QLQ-BM22].
Satoh T, Kobayashi K, Hori T, Iida S, Sato A, Ishiguro H, Chow E, Shimozuma K
Gan to kagaku ryoho. Cancer & chemotherapy 37 ( 8 ) 1507 - 12 2010.8
-
[Clinical development of oral chemotherapeutic agents for advanced gastric cancer].
Sato A, Nakamachi M, Imataka H, Hamada K
Gan to kagaku ryoho. Cancer & chemotherapy 37 ( 7 ) 1192 - 7 2010.7
-
Quality of guideline development assessed by the Evaluation Committee of the Japan Society of Clinical Oncology.
Takuro Shimbo, Tsuguya Fukui, Chikashi Ishioka, Kohji Okamoto, Takahiro Okamoto, Shingo Kameoka, Atsushi Sato, Masakazu Toi, Kunihiko Matsui, Toshihiko Mayumi, Shigetoyo Saji, Masaru Miyazaki, Yuichi Takatsuka, Koichi Hirata
International journal of clinical oncology 15 ( 3 ) 227 - 233 2010.6
-
Phase II study of S-1 as first-line treatment for elderly patients over 75 years of age with advanced gastric cancer: the Tokyo Cooperative Oncology Group study.
Wasaburo Koizumi, Toshikazu Akiya, Atsushi Sato, Toshikazu Sakuyama, Eisaku Sasaki, Takashi Tomidokoro, Tsutomu Hamada, Mototsugu Fujimori, Yoshinori Kikuchi, Ken Shimada, Tetsuya Mine, Kensei Yamaguchi, Tsuneo Sasaki, Minoru Kurihara
Cancer chemotherapy and pharmacology 65 ( 6 ) 1093 - 1099 2010.5
-
アミオダロン塩酸塩速崩錠100mg{TH」及びアミオダロン塩酸塩速崩錠50mg「TH」の生物学的同等性試験
蓮沼智子，豊田幹男，土持一郎，小林亮一，佐藤 隆，佐藤 温
診療と新薬 47 ( 4 ) 369 - 379 2010.4
-
The combination of 5-FU, leucovorin and CPT-11 (FOLFIRI) prolongs survival through inhibition of metastasis in an orthotopic model of colon cancer.
Yoko Ishihara, Kenichi Matsunaga, Hiroko Iijima, Go Hasegawa, Toshimitsu Suzuki, Atsushi Sato, Tomowo Kobayashi, Meng Yang, Robert M Hoffman
Anticancer research 30 ( 2 ) 403 - 408 2010.2
-
[First/second/third-line chemotherapy with molecular targeted drugs for colorectal cancer].
Sato A, Nakamachi M, Imataka H
Gan to kagaku ryoho. Cancer & chemotherapy 36 ( 8 ) 1242 - 6 2009.8
-
[Gastric cancer].
Sato A, Nakamachi M
Gan to kagaku ryoho. Cancer & chemotherapy 36 ( 2 ) 176 - 81 2009.2
-
A phase II study of doxifluridine and docetaxel combination chemotherapy for advanced or recurrent gastric cancer.
Yoshikawa T, Tsuburaya A, Shimada K, Sato A, Takahashi M, Koizumi W, Yoshizawa Y, Nabeshima K, Kimura M, Hataya K, Kobayashi O
Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association 12 ( 4 ) 212 - 8 2009
-
[Clinical development of chemotherapy for advanced gastric cancer].
Sato A, Nakamachi M
Gan to kagaku ryoho. Cancer & chemotherapy 35 ( 9 ) 1461 - 6 2008.9
-
[A feasibility study of oxaliplatin (L-OHP) in combination with infusional 5-FU/l-LV (FOLFOX4 regimen) for advanced colorectal cancer].
Suenaga M, Nishina T, Hyodo I, Munakata M, Koizumi W, Mishima H, Sato A, Mizunuma N, Hatake K
Gan to kagaku ryoho. Cancer & chemotherapy 35 ( 2 ) 255 - 60 2008.2
-
[Clinical development of chemotherapy for advanced gastric cancer].
Sato A, Matsukawa M
Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology 104 ( 2 ) 186 - 93 2007.2
-
[Irinotecan chemotherapy for patients with advanced or relapsed pancreatic neoplasm].
Sekikawa T, Akaike A, Ushio J, Sato A, Matsukawa M
Nihon rinsho. Japanese journal of clinical medicine 64 Suppl 1 203 - 6 2006.1
-
[Pilot-testing of the Japanese version of the EORTC QLQ-STO22 gastric cancer module].
Morita S, Shimozuma K, Sato A, Nakamachi M, Blazeby J, West K, Fukuhara S, Sakamoto J
Gan to kagaku ryoho. Cancer & chemotherapy 31 ( 8 ) 1195 - 9 2004.8